Login / Signup

Willingness to pay for cancer prevention versus treatment in China: Implications for cost-effectiveness threshold.

Zixuan ZhaoYi YangWeijia WuHengjin Dong
Published in: Expert review of pharmacoeconomics & outcomes research (2023)
The findings suggest that though there is a smaller gap between the two scenarios in China as compared to other countries, the WTP may vary under different scenarios. So there's a need to further refine the development of CET by adding parameters like prevention instead of defining one universal threshold.
Keyphrases
  • climate change
  • papillary thyroid
  • squamous cell carcinoma
  • squamous cell